← Back to About Linbro Therapeutics

About Sture Hobro

From dialysis engineering to research on tumor metabolism

Sture Hobro is a mechanical engineer who has devoted most of his career to the development of medical technology for dialysis treatment. He is an inventor named on approximately thirty granted patents and originated the ideas behind the Breakpoint treatment concept. In 2014, he received Baxter’s award for ingenuity.

Since 2017, his work has focused primarily on one question: how can the glucose dependence of tumors be understood and potentially exploited to develop new treatment strategies? He has spent more than 25,000 hours studying tumor metabolism and the scientific literature.

A central idea is therapeutic hypoglycemia: a proposed, brief, controlled state in which glucose availability is sharply reduced while the energy needs of healthy tissues must be protected. The hypothesis is that hypoxic, glycolysis-dependent tumor cells have particularly little metabolic reserve under these conditions. Safe implementation and clinical anticancer efficacy have not yet been established.

Hobro’s engineering approach is to use dialysis to lower and control glucose levels. He has called this dialysis-based method CancerDialysis. The broader proposed treatment strategy is called Therapeutic Hypoglycemia.

The concept was described in Cancers in 2022. An experimental study published in Scientific Reports in 2023 showed that hemodialysis could lower blood glucose while maintaining ketosis in ketogenic-diet-fed rats. The study did not demonstrate an effect on cancer.

Hobro is a co-founder of Linbro Therapeutics AB. Through the company’s advisory service, he helps people with cancer and their families understand research findings and discuss complementary approaches, their proposed mechanisms, evidence and limitations.

Sture Hobro is not a physician. He does not diagnose disease or prescribe cancer treatment. The advisory service does not replace conventional healthcare. Therapeutic Hypoglycemia remains an experimental concept, not an established cancer treatment.

Scientific publications

Explore more